Matsumoto T, Tao W, Sha'afi R I
Department of Physiology, University of Connecticut Health Center, Farmington 06032.
Biochem J. 1988 Mar 1;250(2):343-8. doi: 10.1042/bj2500343.
The presence of a phospholipase A2 (PLA2) activity in rabbit neutrophil membrane preparation that is able to release [1-14C]oleic acid from labelled Escherichia coli has been demonstrated. The activity is critically dependent on the free calcium concentration and marginally stimulated by GTP gamma S. More than 80% of maximal activity is reached at 10 microM-Ca2+. The chemotactic factor, fMet-Leu-Phe, does not stimulate the PLA2 activity in this membrane preparation. Pretreatment of the membrane preparation, under various experimental conditions, or intact cells, before isolation of the membrane with phorbol 12-myristate 13-acetate (PMA), does not affect PLA2 activity. Addition of the catalytic unit of cyclic AMP-dependent kinase to membrane preparation has no effect on PLA2 activity. Pretreatment of the intact neutrophil with dibutyryl-cAMP before isolation of the membrane produces a small but consistent increase in PLA2 activity. The activity of PLA2 in membrane isolated from cells treated with the protein kinase inhibitor 1-(5-isoquinolinesulphonyl)-2-methyl piperazine dihydrochloride (H-7) is significantly decreased. Furthermore, although the addition of PMA to intact rabbit neutrophils has no effect on the release of [3H]arachidonic acid from prelabelled cells, it potentiates significantly the release produced by the calcium ionophore A23187. This potentiation is not due to an inhibition of the acyltransferase activity. H-7 inhibits the basal release of arachidonic acid but does not inhibit the potentiation by PMA. These results suggest several points. (1) fMet-Leu-Phe does not stimulate PLA2 directly, and its ability to release arachidonic acid in intact neutrophils is mediated through its action on phospholipase C. (2) The potentiating effect of PMA on A23187-induced arachidonic acid release is most likely due to PMA affecting either the environment of PLA2 and/or altering the organization of membrane phospholipids in such a way as to increase their susceptibility to hydrolysis. (3) The intracellular level of cyclic AMP probably does not directly affect the activity of PLA2.
已证实在兔中性粒细胞膜制剂中存在一种磷脂酶A2(PLA2)活性,该活性能够从标记的大肠杆菌中释放[1-14C]油酸。该活性严重依赖于游离钙浓度,并受到GTPγS的轻微刺激。在10μM - Ca2+时达到最大活性的80%以上。趋化因子fMet-Leu-Phe在这种膜制剂中不刺激PLA2活性。在各种实验条件下对膜制剂进行预处理,或在用佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)分离膜之前对完整细胞进行预处理,均不影响PLA2活性。向膜制剂中添加环磷酸腺苷依赖性激酶的催化单位对PLA2活性没有影响。在用蛋白激酶抑制剂1-(5-异喹啉磺酰基)-2-甲基哌嗪二盐酸盐(H-7)处理的细胞分离得到的膜中,PLA2的活性显著降低。此外,虽然向完整的兔中性粒细胞中添加PMA对预先标记的细胞中[3H]花生四烯酸的释放没有影响,但它显著增强了钙离子载体A23187产生的释放。这种增强不是由于酰基转移酶活性的抑制。H-7抑制花生四烯酸的基础释放,但不抑制PMA的增强作用。这些结果表明了几点。(1)fMet-Leu-Phe不直接刺激PLA2,其在完整中性粒细胞中释放花生四烯酸的能力是通过其对磷脂酶C的作用介导的。(2)PMA对A23187诱导的花生四烯酸释放的增强作用很可能是由于PMA影响了PLA2的环境和/或改变了膜磷脂的组织方式,从而增加了它们对水解的敏感性。(3)细胞内环磷酸腺苷水平可能不直接影响PLA2的活性。